Home > Insider Trading > Filing (0000914190-21-000183)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
842023	Bio-Techne Corp	TECH	Biological Products, (No Disgnostic Substances) (2836)	411427402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739054	Kim Kelderman	614 Mckinley Place Ne Minneapolis MN 55413	Pres. Diagnostics & Genom	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-06-09	811	$433.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$150.78	2025-05-01	2,652	2,652	Direct
Common Stock	Stock Options (Right to Buy)	$150.78	2025-05-01	7,348	7,348	Direct
Common Stock	Restricted Stock Units	$0.00		1,691	1,691	Direct
Common Stock	Stock Options (Right to Buy)	$177.32	2025-08-08	12,044	12,044	Direct
Common Stock	Stock Options (Right to Buy)	$177.32	2025-08-08	9,033	9,033	Direct
Common Stock	Restricted Stock Units	$0.00		2,363	2,363	Direct
Common Stock	Stock Options (Right to Buy)	$190.41	2026-08-07	11,961	11,961	Direct
Common Stock	Stock Options (Right to Buy)	$190.41	2026-08-07	15,948	15,948	Direct
Common Stock	Restricted Stock Units	$0.00		2,015	2,015	Direct
Common Stock	Stock Options (Right to Buy)	$267.87	2027-08-05	8,991	8,991	Direct
Common Stock	Stock Options (Right to Buy)	$267.87	2027-08-05	11,988	11,988	Direct
Common Stock	Stock Options (Right to Buy)	$267.87	2027-08-05	8,325	8,325	Direct
Common Stock	Stock Options (Right to Buy)	$267.87	2027-08-05	8,325	8,325	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-05-01	2,652	2,652	Direct
2025-05-01	7,348	7,348	Direct
	1,691	1,691	Direct
2025-08-08	12,044	12,044	Direct
2025-08-08	9,033	9,033	Direct
	2,363	2,363	Direct
2026-08-07	11,961	11,961	Direct
2026-08-07	15,948	15,948	Direct
	2,015	2,015	Direct
2027-08-05	8,991	8,991	Direct
2027-08-05	11,988	11,988	Direct
2027-08-05	8,325	8,325	Direct
2027-08-05	8,325	8,325	Direct

Footnotes

Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.